Lonza Launches Scarab Genomics’ High-Yielding Clean Genome® E. coli for Biologics Production

Madison, WI, and Basel, Switzerland, 22 September 2010 – Scarab Genomics, a pioneer in the world of E. coli genomics and production strains, and Lonza, a world leader in biopharmaceutical development and production, announced today the companies have entered into a preferred marketing and sales agreement for Scarab Genomics’ Clean Genome® E. coli. Financial details of the contract were not disclosed.

To read the full press release click here

Click here to visit Lonza's website